Articles Mentioning Defensive Stocks

Results 1 - 10 of 112 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Defensive

Investing | October 02, 2014

Why Allergan Inc. Is an Activist Investor Target

Botox-maker Allergan has attracted activist investors in droves lately. Here's why.

Investing | July 05, 2014

This Week in Biotech: Allergan Three-Peats in a Bad Way While Agenus Impresses

An early FDA approval, an inhaled therapy being turned away by regulators for a third time, and three positive clinical updates are this week's top biotech stories.

Investing | February 05, 2014

Valeant's Inorganic Growth Could Threaten These 3 Companies in 2014

Valeant just made its first acquisition of the year. Let’s take a closer look at three companies -- Allergan, Actavis, and Zeltiq -- which could be threatened by the company’s inorganic growth.

Investing | November 03, 2013

Is Abbott Labs Destined for Greatness?

Let's see what the numbers say about Abbott (ABT).

Investing | October 23, 2013

Amarin, Cubist Pharmaceuticals, and Abaxis Could Be Big Movers Today

Keep an eye on Amarin, Cubist, and Abaxis -- they could make big moves during today's trading.

Investing | August 16, 2013

The Collapse of Coal

A confluence of factors is killing off coal plants one by one.

Investing | June 12, 2013

Can This Experimental Drug Be Brought Back From the Dead?

Written off for dead in 2009, this drug may show increased efficacy at higher doses.

Investing | June 12, 2013

What Do Dividend Stocks, Coal, and Cameroon Have in Common?

The Tony Awards of utilities have been announced.

Investing | April 24, 2013

This Dividend Stock Just Pushed up Its Payout

Can this utility electrify your earnings?

Investing | February 23, 2013

Ameren Earnings: 1 Dividend That's Here to Stay

The utility opts for regulation over generation.

Results 1 - 10 of 112 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Defensive